VictorYoussefYazbeckMD, MS

PubMed

• Advances in Hodgkin's lymphoma pharmacotherapy: a focus on histone deacetylase inhibitors.
  Thuy Ho, Cara Coleman, Palak Shah, Victor Yazbeck> ;Expert Opinion on Pharmacotherapy. 2023 Jun 2
• Outcomes of Cancer Patients with COVID-19: The Virginia Commonwealth University Experience.
  Patrick J Willard, Yiwei Hang, Temitayo Olasehinde, Naji Bou Zeid, Edem Defor, Dipankar Bandyopadhyay, Victor Yazbeck> ;Cancer Investigation. 2023 May 1
• 4 citations
  PI3k Inhibitors in NHL and CLL: An Unfulfilled Promise.
  Naji Bou Zeid, Victor Yazbeck> ;Blood and Lymphatic Cancer. 2023 Jan 1
• Melanoma Treatment: The Heart Has Skin in the Game.
  Adolfo G Mauro, Victor Yazbeck, Fadi N Salloum> ;JACC. Cardiooncology. 2022 Nov 1
• Systemic Relapse in a Young Adult Patient with Primary CNS Diffuse Large B-Cell Lymphoma.
  Adam Khorasanchi, Zachary Benson, Misty Hall, Nelya Ebadirad, Mohammad H Gharavi, Patrick Willard, Miranda Chimzar, John McKay, Gary Simmons, Victor Yazbeck> ;Case Reports in Hematology. 2022 Jan 1
• 13 citations
  An overview of chemotoxicity and radiation toxicity in cancer therapy.
  Victor Yazbeck, Erin Alesi, Jennifer Myers, Mary Helen Hackney, Laurie Cuttino, David A Gewirtz> ;Advances in Cancer Research. 2022 Jan 1
• 3 citations
  Role of antibody-based therapy in indolent non-Hodgkin's lymphoma.
  Patrick J Willard, John McKay, Victor Yazbeck> ;Leukemia Research Reports. 2021 Jan 1
• 3 citations
  Phase 1 study of belinostat (PXD-101) and bortezomib (Velcade, PS-341) in patients with relapsed or refractory acute leukemia and myelodysplastic syndrome.
  Beata Holkova, Danielle Shafer, Victor Yazbeck, Sandeep S. Dave, Prithviraj Bose, Mary Beth Tombes, Ellen Shrader, Wen Wan, Dipankar Bandyopadhyay, Caryn Weir, Elizabe...> ;Leukemia & Lymphoma. 2021 Apr 16
• 8 citations
  Perspectives on chemotherapy for the management of double-hit lymphoma.
  Taha Al-Juhaishi, John McKay, Ariel Sindel, Victor Yazbeck> ;Expert Opinion on Pharmacotherapy. 2020 Feb 17
• 37 citations
  Marginal Zone Lymphoma: State-of-the-Art Treatment
  Ariel Sindel, Taha Al-Juhaishi, Victor Yazbeck> ;Current Treatment Options in Oncology. 2019 Dec 5
• 1 citations
  Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occurandand proceed through multiple mechanisms.
  Tri Nguyen, Rebecca Parker, Elisa Hawkins, Beata Holkova, Victor Yazbeck, Akhil Kolluri, Maciej Kmieciak, Mohamed Rahmani, Steven Grant> ;Oncotarget. 2019 Sep 3
• 2 citations
  Case of a CD3 Negative Hepatosplenic T-Cell Lymphoma: Diagnostic and Therapeutic Challenges
  Laura Alder, Scott Graupner, Guanhua Lai, Victor Yazbeck> ;Case Reports in Hematology. 2019 Jun 27
• 6 citations
  Choosing the right pharmacotherapy for non-Hodgkin's lymphoma: does one size fit all?
  Taha Al Juhaishi, Victor Yazbeck> ;Expert Opinion on Pharmacotherapy. 2019 Feb 22
• 32 citations
  A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma
  Victor Yazbeck, Danielle Shafer, Edward B. Perkins, Domenico Coppola, Lubomir Sokol, Kristy L. Richards, Thomas B. Shea, Jia Ruan, Samir Parekh, Roger Strair, Christop...> ;Clinical Lymphoma, Myeloma & Leukemia. 2011 Nov 18
• 2 citations
  Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms.
  Tri Nguyen, Rebecca Parker, Elisa Hawkins, Beata Holkova, Victor Yazbeck, Akhil Kolluri, Maciej Kmieciak, Mohamed Rahmani, Steven Grant> ;Oncotarget. 2017 May 9
• 1 citations
  Treatment of Primary Central Nervous System Posttransplant Lymphoproliferative Disorder in an Adult Kidney Transplant Recipient: A Case Report.
  Mashya Abbassi, Roger S. Riley, Mark G. Malkin, Yang Tang, Bipin Rajendran, Victor Yazbeck> ;Experimental and Clinical Transplantation. 2017 Apr 27
• 18 citations
  A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymp...
  Beata Holkova, Victor Yazbeck, Maciej Kmieciak, Prithviraj Bose, Shuo Ma, Amy S. Kimball, Mary Beth Tombes, Ellen Shrader, Wen Wan, Caryn Weir-Wiggins, Amanda Garnett ...> ;Leukemia & Lymphoma. 2017 Jan 19
• 18 citations
  Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas.
  Beata Holkova, Maciej Kmieciak, Prithviraj Bose, Victor Yazbeck, Paul M. Barr, Mary Beth Tombes, Ellen Shrader, Caryn Weir-Wiggins, April D. Rollins, Erin Cebula, Emil...> ;Leukemia & Lymphoma. 2016 Mar 3
• 13 citations
  Romidepsin for the treatment of non-Hodgkin's lymphoma.
  Victor Yazbeck, Steven Grant> ;Expert Opinion on Investigational Drugs. 2015 Jun 22
• 18 citations
  Single-agent obatoclax (GX15-070) potently induces apoptosis and pro-survival autophagy in head and neck squamous cell carcinoma cells
  Victor Y. Yazbeck, Changyou Li, Jennifer R. Grandis, Yan Zang, Daniel Johnson> ;Oral Oncology. 2014 Feb 1
• 23 citations
  Management of normal tissue toxicity associated with chemoradiation (primary skin, esophagus, and lung).
  Victor Y. Yazbeck, Liza C. Villaruz, Marsha Haley, Mark A. Socinski> ;Cancer Journal. 2013 May 1
• 22 citations
  Primary central nervous system post-transplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation.
  Frank S. Lieberman, Victor Y. Yazbeck, Anastasios Raptis, Raymond E. Felgar, Michael Boyiadzis> ;Journal of Neuro-Oncology. 2012 Apr 1
• 114 citations
  Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma.
  Victor Yazbeck, Daniela Buglio, Georgios V. Georgakis, Yang Li, Eiji Iwado, Jorge E. Romaguera, Seiji Kondo, Anas Younes> ;Experimental Hematology. 2008 Apr 1
• 3 citations
  Hodgkin’s lymphoma: molecular targets and novel treatment strategies
  Victor Yazbeck, Georgios V. Georgakis, Amanda Wedgwood, Anas Younes> ;Future Oncology. 2006 Aug 21
• 89 citations
  Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-κB activation
  Rihab Nasr, Estelle Chiari, Marwan El-Sabban, Renaud Mahieux, Youmna Kfoury, Maher Abdul-Hay, Victor Yazbeck, Olivier Hermine, Claudine Pique, Ali Bazarbachi> ;Blood. 2006 May 15
• Join now to see all

Abstracts/Posters

• Brentuximab Vedotin in Front-Line Therapy of Hodgkin Lymphoma (HL) and CD30-Expressing Peripheral T-Cell Lymphoma (PTCL) in Adults Age 60 and Above
  Victor Yazbeck, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Phase 2 Study of Frontline Brentuximab Vedotin Plus Nivolumab in Patients with Hodgkin Lymphoma Aged _60 YearsClinically Relevant Abstract
  Victor Yazbeck, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Primary Ocular Lymphoma: A SEER Database Analysis of Patterns of Involvement and Outcomes
  Victor Yazbeck, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019